
|Videos|April 14, 2022
Patient-Centered Oncology Care
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Latest CME
Trending on AJMC
1
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
2
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
3
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
4
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
5








































